• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intratumoral heterogeneity of Notch1 expression in small cell lung cancer.

作者信息

Ito Takaaki

机构信息

Department of Pathology and Experimental Medicine, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.

出版信息

J Thorac Dis. 2018 Mar;10(3):1272-1275. doi: 10.21037/jtd.2018.03.61.

DOI:10.21037/jtd.2018.03.61
PMID:29707277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5906247/
Abstract
摘要

相似文献

1
Intratumoral heterogeneity of Notch1 expression in small cell lung cancer.小细胞肺癌中Notch1表达的肿瘤内异质性。
J Thorac Dis. 2018 Mar;10(3):1272-1275. doi: 10.21037/jtd.2018.03.61.
2
Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.程序性细胞死亡配体-1表达的肿瘤内异质性在肺癌中很常见。
PLoS One. 2017 Oct 19;12(10):e0186192. doi: 10.1371/journal.pone.0186192. eCollection 2017.
3
Intratumoral heterogeneity of KRAS mutation is rare in non-small-cell lung cancer.非小细胞肺癌中 KRAS 突变的肿瘤内异质性罕见。
Exp Mol Pathol. 2013 Feb;94(1):155-9. doi: 10.1016/j.yexmp.2012.09.016. Epub 2012 Sep 27.
4
Effects of the Notch1 signaling pathway on human lung cancer A549 cells.Notch1信号通路对人肺癌A549细胞的影响。
Exp Lung Res. 2017 May-Jun;43(4-5):208-216. doi: 10.1080/01902148.2017.1341008. Epub 2017 Jul 18.
5
Intratumoral heterogeneity of copy number variation in lung cancer harboring L858R via immunohistochemical heterogeneous staining.肺癌中 L858R 通过免疫组化异质性染色的拷贝数变异的肿瘤内异质性。
Lung Cancer. 2018 Oct;124:241-247. doi: 10.1016/j.lungcan.2018.08.013. Epub 2018 Aug 13.
6
Expression of Notch1 and Numb in small cell lung cancer.Notch1和Numb在小细胞肺癌中的表达。
Oncotarget. 2017 Feb 7;8(6):10348-10358. doi: 10.18632/oncotarget.14411.
7
Pathobiology of Notch2 in lung cancer.肺癌中Notch2的病理生物学
Pathology. 2017 Aug;49(5):486-493. doi: 10.1016/j.pathol.2017.05.005. Epub 2017 Jun 27.
8
Notch1 signaling controls cell proliferation, apoptosis and differentiation in lung carcinoma.Notch1信号通路调控肺癌细胞的增殖、凋亡和分化。
Lung Cancer. 2014 Aug;85(2):131-40. doi: 10.1016/j.lungcan.2014.05.001. Epub 2014 May 13.
9
[Expression of CD133 and Notch1 in non-small cell lung cancer and the clinicopathological significance].[CD133和Notch1在非小细胞肺癌中的表达及其临床病理意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2015 Feb;35(2):196-201.
10
Notch1 destabilizes the adherens junction complex through upregulation of the Snail family of E-cadherin repressors in non-small cell lung cancer. Notch1 通过上调非小细胞肺癌中 Snail 家族 E-钙黏蛋白抑制剂使黏附连接复合体不稳定。
Oncol Rep. 2013 Sep;30(3):1423-9. doi: 10.3892/or.2013.2565. Epub 2013 Jun 26.

引用本文的文献

1
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects.神经内分泌肿瘤铂类化疗敏感性相关改变途径概述：优势与前景。
Int J Mol Sci. 2024 Aug 6;25(16):8568. doi: 10.3390/ijms25168568.
2
Molecular basis of heterogeneity in small cell lung cancer.小细胞肺癌异质性的分子基础。
Transl Cancer Res. 2022 Dec;11(12):4237-4240. doi: 10.21037/tcr-22-2224.
3
Notch signaling pathway: architecture, disease, and therapeutics.Notch 信号通路：结构、疾病与治疗。
Signal Transduct Target Ther. 2022 Mar 24;7(1):95. doi: 10.1038/s41392-022-00934-y.
4
The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy.Notch1、Hes1、Ascl1 和 DLL3 蛋白表达对接受铂类化疗的 SCLC 患者的预后意义。
PLoS One. 2020 Oct 26;15(10):e0240973. doi: 10.1371/journal.pone.0240973. eCollection 2020.

本文引用的文献

1
Tumour heterogeneity and resistance to cancer therapies.肿瘤异质性与癌症治疗耐药性。
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94. doi: 10.1038/nrclinonc.2017.166. Epub 2017 Nov 8.
2
Reciprocal expression of INSM1 and YAP1 defines subgroups in small cell lung cancer.INSM1和YAP1的相互表达定义了小细胞肺癌中的亚组。
Oncotarget. 2017 Aug 28;8(43):73745-73756. doi: 10.18632/oncotarget.20572. eCollection 2017 Sep 26.
3
Small-cell lung cancer: what we know, what we need to know and the path forward.小细胞肺癌：我们已知的、需要知道的以及未来的发展方向。
Nat Rev Cancer. 2017 Dec;17(12):725-737. doi: 10.1038/nrc.2017.87. Epub 2017 Oct 27.
4
Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.肿瘤内异质性：解析基因组结构和克隆进化的新方法。
Mol Cancer Res. 2017 Sep;15(9):1127-1137. doi: 10.1158/1541-7786.MCR-17-0070. Epub 2017 Jun 8.
5
Unravelling the biology of SCLC: implications for therapy.揭示小细胞肺癌的生物学特性：对治疗的启示
Nat Rev Clin Oncol. 2017 Sep;14(9):549-561. doi: 10.1038/nrclinonc.2017.71. Epub 2017 May 23.
6
Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.Notch信号传导产生的肿瘤内异质性促进小细胞肺癌。
Nature. 2017 May 18;545(7654):360-364. doi: 10.1038/nature22323. Epub 2017 May 10.
7
Correlation between histone acetylation and expression of Notch1 in human lung carcinoma and its possible role in combined small-cell lung carcinoma.组蛋白乙酰化与人类肺癌中Notch1表达的相关性及其在小细胞肺癌合并症中的可能作用。
Lab Invest. 2017 Aug;97(8):913-921. doi: 10.1038/labinvest.2017.36. Epub 2017 Apr 17.
8
Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.小细胞肺癌，一种类似上皮-间质转化（EMT）的癌症：无活性Notch信号传导的意义及achaete-scute复合体同源物1的表达
Hum Cell. 2017 Jan;30(1):1-10. doi: 10.1007/s13577-016-0149-3. Epub 2016 Oct 26.
9
ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs.ASCL1和NEUROD1揭示了肺神经内分泌肿瘤的异质性并调控不同的基因程序。
Cell Rep. 2016 Aug 2;16(5):1259-1272. doi: 10.1016/j.celrep.2016.06.081. Epub 2016 Jul 21.
10
Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?小细胞肺癌：生物学和分子生物学的最新进展能否转化为更好的治疗结果？
J Thorac Oncol. 2016 Apr;11(4):453-74. doi: 10.1016/j.jtho.2016.01.012. Epub 2016 Jan 30.